The Ticagrelor Market is estimated to be valued at US$ 1285.83 Mn in 2023 and is expected to exhibit a CAGR of 12% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Ticagrelor is an antiplatelet drug used to treat acute coronary syndromes, including heart attacks and unstable angina. It works by inhibiting platelet activation and aggregation, thereby reducing the risk of blood clots. Ticagrelor tablets are prescribed along with aspirin to help prevent chest pain, heart attack or stroke in patients with a history of heart attack or chest pain.

Market Dynamics:
The Ticagrelor market is expected to witness significant growth over the forecast period owing to rising prevalence of coronary artery disease. According to World Health Organization, cardiovascular diseases account for over 17.9 million deaths globally every year, out of which coronary artery disease stands as the single largest killer. Moreover, growing geriatric population who are more prone to developing heart diseases is also driving the market growth. Furthermore, favorable reimbursement policies and availability of generic versions of ticagrelor are improving its accessibility and aiding market expansion. However, issues pertaining to increased risk of bleeding associated with ticagrelor and availability of alternative treatments may hamper market growth over the forecast period.

For more insights, read- http://insightfulmarket.weebly.com/blog/ticagrelor-an-antiplatelet-drug-is-fueling-growth-of-the-global-ticagrelor-market